Ike Davis says he still had valley fever symptoms last year

17 Comments

John Hickey’s latest story in the Mercury-News reports that new Oakland Athletics first baseman Ike Davis was still suffering from some effects of valley fever last year. A disease he first contracted in 2012:

“Valley fever is a nightmare,” said Davis, who turns 28 in March. “You have no energy, no nothing. It was definitely a weird one. It’s supposed to go away on its own, but when I had an X-ray last year, it showed I still had it. I’m hoping that’s over and done with.”

At various points Davis has said that the was asymptomatic, such as in this March 2012 story, but then it came back strong in early 2013 and many attribute it to his struggles that season. And, apparently, last season as well.

The central question surrounding Davis for the past several years was whether he can ever be the player he suggested he’d become after his 2011 and 2012 seasons. If, as Davis says, his valley fever has persisted like this, it would go a long way toward explaining why the past two years have been so rough for him.

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
1 Comment

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.